| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/21/2007 | CN1931358A Orally administered peptides to ameliorate atherosclerosis |
| 03/21/2007 | CN1931342A Medicine for eliminating acne |
| 03/21/2007 | CN1931340A Leukoderma treating Chinese medicine prepn |
| 03/21/2007 | CN1931311A Psoriasis treating Chinese medicine prepn |
| 03/21/2007 | CN1931310A Psoriasis treating Chinese medicine prepn |
| 03/21/2007 | CN1931309A Beautifying and spot eliminating health care product and its prepn process |
| 03/21/2007 | CN1931308A Dermatosis treating medicine |
| 03/21/2007 | CN1931297A Medicine for treating scalds |
| 03/21/2007 | CN1931284A Leucoderma treating Chinese medicine prepn |
| 03/21/2007 | CN1931283A Orally taken pearl liquid and its production process |
| 03/21/2007 | CN1931282A Chinese medicine composition for promoting blood circulation to eliminate spots and its prepn process |
| 03/21/2007 | CN1931278A Orally taken Chinese medicine for preventing and treating frostbite |
| 03/21/2007 | CN1931268A Acne treating medicine |
| 03/21/2007 | CN1931265A Externally applied Chinese medicine spray for treating burns and scalds |
| 03/21/2007 | CN1931264A Compound externally applied filming Chinese medicine spray for treating frostbite |
| 03/21/2007 | CN1931263A Externally applied Chinese medicine for treating acne and folliculitis |
| 03/21/2007 | CN1931253A Leucoderma treating Chinese medicine |
| 03/21/2007 | CN1931246A Medicine for treating burns and scalds and its prepn process |
| 03/21/2007 | CN1931241A Chinese medicine reductant liquid for treating scar and its prepn process |
| 03/21/2007 | CN1931222A Medicinal wine for treating furuncle |
| 03/21/2007 | CN1931220A Medicine paste for treating burns and scalds and its prepn process |
| 03/21/2007 | CN1931198A Wound protecting and treating smearing prepn |
| 03/21/2007 | CN1931193A Medicine for treating various types of noxious sore, angiitis and stomatocace |
| 03/21/2007 | CN1931190A Toad skin extract and its medicine prepn and their prepn |
| 03/21/2007 | CN1931180A Medicines of different characters and their prepn and use |
| 03/21/2007 | CN1931134A Nanometer solid isovitamin A acid lipoid particle and its prepn process |
| 03/21/2007 | CN1931132A Externally applied filming medicine spray |
| 03/21/2007 | CN1305872C Process for producing quinazoline ditosylate salt compounds |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305500C Bromhidrosis treating paste |
| 03/21/2007 | CN1305486C Burn treating ointment and making method thereof |
| 03/21/2007 | CN1305476C Skin scream for treating intractable dermatosis |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/21/2007 | CN1305464C Temperature-reducing refreshing aerosol |
| 03/21/2007 | CN1305460C Sugar intake promoters |
| 03/20/2007 | US7193108 Phenylpropionic acid derivatives |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192960 Sodium channel blockers |
| 03/20/2007 | US7192959 Sodium channel blockers |
| 03/20/2007 | US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | US7192942 Wet milling while crystallizing to obtain a primary particle suspension. |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192617 camu camu seed extract as an active component, wherein the whitening agent does not comprise camu camu pulp extract |
| 03/20/2007 | US7192616 Slow down or even inhibit cellular differentiation and/or proliferation. |
| 03/20/2007 | US7192613 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 03/20/2007 | US7192607 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 03/20/2007 | US7192602 safe on the skin when in contact with humans, is toxicologically harmless, and is especially suitable for consumption |
| 03/20/2007 | US7192586 Topical administration of an anti-PSMA antibody alone or conjugated to a cytotoxic moiety to the extracellular domain of human prostate specific membrane antigen (PSMA); anti-proliferative agents and - carcinogenic agents |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | US7192575 Antimicrobial composition |
| 03/20/2007 | CA2438768C Improved flexible collodion compositions |
| 03/20/2007 | CA2315115C Compositions of microspheres for wound healing |
| 03/15/2007 | WO2007029847A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity |
| 03/15/2007 | WO2007029345A1 Tyrosinase activity inhibitor |
| 03/15/2007 | WO2007013078A3 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |
| 03/15/2007 | WO2006136244A3 Use of adipose tissue-derived stromal stem cells in treating fistula |
| 03/15/2007 | WO2006133164A3 Anti-trkb monoclonal antibodies and uses thereof |
| 03/15/2007 | US20070060619 Nicotinamide-based kinase inhibitors |
| 03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060553 3-Nitrogen-6,7-dioxygen steroids and uses related thereto |
| 03/15/2007 | US20070060546 Novel use of mifepristone and derivatives therefor as hedgehog protein signaling pathway modulators and applications of same |
| 03/15/2007 | US20070060538 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/15/2007 | US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 03/15/2007 | US20070059341 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 03/15/2007 | US20070059314 Novel anti-angiogenic agent and its use in particular within the framework of the treatment of cancer |
| 03/15/2007 | US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE) |
| 03/15/2007 | US20070059305 Neutralizing human anti-IGFR antibody |
| 03/15/2007 | US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent |
| 03/15/2007 | DE102006031630A1 Composition for topical application, useful as a cosmetic or dermatological product, contains finely divided barium sulfate |
| 03/15/2007 | CA2621470A1 Bicyclic aromatic substituted pyridone derivative |
| 03/14/2007 | EP1762610A1 Truncated dance, dance complex and method of using these |
| 03/14/2007 | EP1762557A2 Aspirin-triggered lipid mediators |
| 03/14/2007 | EP1762247A1 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissue in humans and animals |
| 03/14/2007 | EP1762241A1 Compositions and methods for mitigating skin irritation |
| 03/14/2007 | EP1762240A1 Compositions for inhibiting or reducing inflammation of skin |
| 03/14/2007 | EP1762227A2 Compositions, uses and kits for treating allergic dermatitis of skin |
| 03/14/2007 | EP1761494A1 Chemical compounds i |
| 03/14/2007 | EP1761491A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
| 03/14/2007 | EP1761485A1 Amidino compounds as cysteine protease inhibitors |
| 03/14/2007 | EP1761266A2 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders |
| 03/14/2007 | EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/14/2007 | EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same |
| 03/14/2007 | EP1450760B1 Itch-relieving cosmetic and dermatological preparations |
| 03/14/2007 | EP1427394B1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities |
| 03/14/2007 | EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 03/14/2007 | EP1305434B1 A human disintegrin protein |
| 03/14/2007 | EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 03/14/2007 | EP1112057B1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 03/14/2007 | CN1930149A Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1929851A Bioactive compositions from theacea plants and processes for their production and use |
| 03/14/2007 | CN1929825A Dermatologic soft gel compositions |
| 03/14/2007 | CN1927393A Composite collagen gel |
| 03/14/2007 | CN1927380A Traditional Chinese medicine for treating dermatosis and its preparation |
| 03/14/2007 | CN1927369A Medicine for curing burn and scald wound and its preparation method |